| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
COO, CLO, Compliance Officer | COO, CLO, Secretary, Compliance Officer | General Counsel & Secretary
2 companies
Jennifer Bush is COO, CLO, Compliance Officer at ARTV, with reported holdings spanning 2 companies. Jennifer Bush's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.5M at current prices.
Jennifer Bush's largest disclosed position is in ARTV as COO, CLO, Compliance Officer, worth about $1.5M. The ARTV filings lean toward selling, a net 33,990 shares.
Jennifer Bush has 32 Form 4 filings on record from June 2015 to November 2026, across 2 companies: COO, CLO, Compliance Officer at Artiva Biotherapeutics (ARTV), 2024–2026; General Counsel & Secretary at VivoSim Labs (VIVS), 2015–2020.
The 43 reported transactions were 21 tax withholdings, 9 stock awards, 5 option or other derivative awards and 4 open-market sales, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 4 sales worth about $265K.
The largest open-market sale was 8,391 shares of ARTV at an average $11.16 on September 3, 2026, about $94K.
None of the 4 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | ARTV Artiva Biotherapeutics, Inc. | COO, CLO, Compliance Officer | Sell | 8,439 | $4.18 | $35,284.30 | -2.3% | - | - | |
| Oct 5, 2026 | ARTV Artiva Biotherapeutics, Inc. | COO, CLO, Compliance Officer | Sell | 8,370 | $6.84 | $57,227.36 | -2.2% | - | - | |
| Sep 3, 2026 | ARTV Artiva Biotherapeutics, Inc. | COO, CLO, Compliance Officer | Sell | 8,391 | $11.16 | $93,605.80 | -2.5% | - | - | |
| May 19, 2026 | ARTV Artiva Biotherapeutics, Inc. | COO, CLO, Compliance Officer | Sell | 8,790 | $9.01 | $79,178.56 | -2.5% | +37.3% | - |